• Abdel-Wahab, O. (2011) Genetics of the myeloproliferative neoplasms. Current Opinion in Hematology, 18, 117123.
  • Abdel-Wahab, O., Pardanani, A., Rampal, R., Lasho, T.L., Levine, R.L. & Tefferi, A. (2011) DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms. Leukemia, 25, 12191220.
  • Butcher, C.M., Hahn, U., To, L.B., Gecz, J., Wilkins, E.J., Scott, H.S., Bardy, P.G. & D’Andrea, R.J. (2008) Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients. Leukemia, 22, 870873.
  • Jia, D., Jurkowska, R.Z., Zhang, X., Jeltsch, A. & Cheng, X. (2007) Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation. Nature, 449, 248251.
  • Ley, T.J., Ding, L., Walter, M.J., McLellan, M.D., Lamprecht, T., Larson, D.E., Kandoth, C., Payton, J.E., Baty, J., Welch, J., Harris, C.C., Lichti, C.F., Townsend, R.R., Fulton, R.S., Dooling, D.J., Koboldt, D.C., Schmidt, H., Zhang, Q., Osborne, J.R., Lin, L., O’Laughlin, M., McMichael, J.F., Delehaunty, K.D., McGrath, S.D., Fulton, L.A., Magrini, V.J., Vickery, T.L., Hundal, J., Cook, L.L., Conyers, J.J., Swift, G.W., Reed, J.P., Alldredge, P.A., Wylie, T., Walker, J., Kalicki, J., Watson, M.A., Heath, S., Shannon, W.D., Varghese, N., Nagarajan, R., Westervelt, P., Tomasson, M.H., Link, D.C., Graubert, T.A., DiPersio, J.F., Mardis, E.R. & Wilson, R.K. (2011) DNMT3A mutations in acute myeloid leukemia. New England Journal of Medicine, 363, 24242433.
  • Schaub, F.X., Looser, R., Li, S., Hao-Shen, H., Lehmann, T., Tichelli, A. & Skoda, R.C. (2011) Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood, 115, 20032007.
  • Stegelmann, F., Bullinger, L., Schlenk, R.F., Paschka, P., Griesshammer, M., Blersch, C., Kuhn, S., Schauer, S., Dohner, H. & Dohner, K. (2011) DNMT3A mutations in myeloproliferative neoplasms. Leukemia, 25, 12171219.
  • Tefferi, A. (2010) Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia, 24, 11281138.
  • Walter, M.J., Ding, L., Shen, D., Shao, J., Grillot, M., McLellan, M., Fulton, R., Schmidt, H., Kalicki-Veizer, J., O’Laughlin, M., Kandoth, C., Baty, J., Westervelt, P., Dipersio, J.F., Mardis, E.R., Wilson, R.K., Ley, T.J. & Graubert, T.A. (2011) Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia, 25, 11531158.
  • Yan, X.J., Xu, J., Gu, Z.H., Pan, C.M., Lu, G., Shen, Y., Shi, J.Y., Zhu, Y.M., Tang, L., Zhang, X.W., Liang, W.X., Mi, J.Q., Song, H.D., Li, K.Q., Chen, Z. & Chen, S.J. (2011) Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nature Genetics, 43, 309315.